Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C genotypes in Finland determined by RFLP

P Pohjanpelto1, M Lappalainen, A Widell

  • 1Department of Virology, Haartman Institute, University of Helsinki, Finland.

Clinical and Diagnostic Virology
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low incidence of severe bacterial infections in hospitalised patients with COVID-19: A population-based registry study.

Infectious diseases (London, England)·2022
Same author

COVID-19 cases in spectators returning to Finland from UEFA Euro 2020 matches in Saint Petersburg.

Epidemiology and infection·2022
Same author

Detection of SARS-CoV-2 RNA on surfaces in a COVID-19 hospital ward indicates airborne viral spread.

The Journal of hospital infection·2022
Same author

Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection.

Journal of virological methods·2022
Same author

Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2021
Same author

Laboratory-based surveillance of COVID-19 in the Greater Helsinki area, Finland, February-June 2020.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2020

Hepatitis C virus (HCV) genotyping reveals genotype 3a is prevalent in Finnish patients, particularly among younger individuals and intravenous drug users. This study utilized a rapid RFLP method for accurate HCV typing.

Area of Science:

  • Virology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) genotyping is crucial for understanding disease transmission and guiding clinical management.
  • Accurate and efficient HCV typing methods are essential for epidemiological surveillance.

Purpose of the Study:

  • To determine the distribution of HCV genotypes in various patient groups in Finland.
  • To evaluate a rapid and reliable HCV typing method based on RFLP.

Main Methods:

  • HCV genotyping was performed using a restriction fragment length polymorphism (RFLP) assay.
  • The RFLP method analyzed the amplified 5' non-coding region of the HCV genome.
  • A nested, one-tube PCR system was employed for initial DNA amplification.

Related Experiment Videos

Main Results:

  • In 264 Finnish sera, the identified HCV genotypes were 1a (14%), 1b (24%), 2b (20%), 3a (41%), and a mixed 1a+1b (1%).
  • HCV genotype 2a was identified in only one patient.
  • Among Egyptian blood donors, HCV types 1b and 4 were detected.
  • HCV genotype 3a showed a higher association with intravenous drug abuse and individuals under 30 years of age.

Conclusions:

  • The RFLP-based method provides a rapid and reliable approach for HCV genotyping.
  • HCV genotype 3a is the most prevalent in the studied Finnish population, with specific demographic associations.
  • Understanding HCV genotype distribution is vital for public health strategies and patient care.